HK1207289A1 - 用於在失血和貧血的治療中預防血管活性的組合物 - Google Patents

用於在失血和貧血的治療中預防血管活性的組合物

Info

Publication number
HK1207289A1
HK1207289A1 HK15107860.5A HK15107860A HK1207289A1 HK 1207289 A1 HK1207289 A1 HK 1207289A1 HK 15107860 A HK15107860 A HK 15107860A HK 1207289 A1 HK1207289 A1 HK 1207289A1
Authority
HK
Hong Kong
Prior art keywords
vasoactivity
anemia
prevention
treatment
composition
Prior art date
Application number
HK15107860.5A
Other languages
English (en)
Inventor
Jan Blumenstein
Original Assignee
Jan Blumenstein
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jan Blumenstein filed Critical Jan Blumenstein
Publication of HK1207289A1 publication Critical patent/HK1207289A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
HK15107860.5A 2012-04-11 2015-08-14 用於在失血和貧血的治療中預防血管活性的組合物 HK1207289A1 (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261622615P 2012-04-11 2012-04-11
US201261622612P 2012-04-11 2012-04-11
US13/796,110 US20130274245A1 (en) 2012-04-11 2013-03-12 Composition For Prevention of Vasoactivity in the Treatment of Blood Loss and Anemia
PCT/CA2013/050278 WO2013152441A1 (en) 2012-04-11 2013-04-05 Composition for prevention of vasoactivity in the treatment of blood loss and anemia

Publications (1)

Publication Number Publication Date
HK1207289A1 true HK1207289A1 (zh) 2016-01-29

Family

ID=49325633

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15107860.5A HK1207289A1 (zh) 2012-04-11 2015-08-14 用於在失血和貧血的治療中預防血管活性的組合物

Country Status (12)

Country Link
US (2) US20130274245A1 (zh)
EP (1) EP2836215A4 (zh)
JP (1) JP2015512917A (zh)
KR (1) KR20150003797A (zh)
CN (1) CN104349778A (zh)
AU (1) AU2013247357A1 (zh)
CA (1) CA2869315A1 (zh)
HK (1) HK1207289A1 (zh)
IL (1) IL235035A0 (zh)
IN (1) IN2014DN08295A (zh)
RU (1) RU2014142801A (zh)
WO (1) WO2013152441A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10872307B2 (en) * 2013-12-27 2020-12-22 Fenwal, Inc. System and method for blood component supply chain management
US20220387433A1 (en) * 2019-11-12 2022-12-08 American Regent, Inc. Type v phosphodiesterase inhibitor compositions, methods of making them and methods of using them in preventing or treating elevated pulmonary vascular pressure or pulmonary hemorrhages
CN116042763A (zh) * 2023-03-07 2023-05-02 中国人民解放军军事科学院军事医学研究院 一种放大血管活性的方法、产品及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA878182B (en) * 1986-11-05 1988-05-02 Merrell Dow Pharmaceuticals Inc. Enhancement of prazosin
US20030040514A1 (en) * 1999-11-12 2003-02-27 Wyllie Michael G. Combination effective for the treatment of impotence
US6894150B1 (en) * 1999-10-01 2005-05-17 Ross Walden Tye Non-pyrogenic, endotoxin-free, stroma-free tetrameric hemoglobin
WO2008019106A1 (en) * 2006-08-04 2008-02-14 Artesian Therapeutics, Inc. Methods and compositions for the treatment of pulmonary hypertension using a combination of a calcium channel blocker and a phosphodiesterase inhibitor
US7504377B2 (en) * 2006-10-23 2009-03-17 Ikor, Inc. Nitric oxide-blocked cross-linked tetrameric hemoglobin
KR101548692B1 (ko) * 2006-11-07 2015-09-01 더 제너럴 하스피탈 코포레이션 가스 전달 장치

Also Published As

Publication number Publication date
US20130274245A1 (en) 2013-10-17
IN2014DN08295A (zh) 2015-05-15
JP2015512917A (ja) 2015-04-30
US20150290213A1 (en) 2015-10-15
US20160206623A9 (en) 2016-07-21
KR20150003797A (ko) 2015-01-09
RU2014142801A (ru) 2016-05-27
IL235035A0 (en) 2014-12-31
EP2836215A4 (en) 2016-06-08
CN104349778A (zh) 2015-02-11
WO2013152441A1 (en) 2013-10-17
AU2013247357A1 (en) 2014-10-23
CA2869315A1 (en) 2013-10-17
EP2836215A1 (en) 2015-02-18

Similar Documents

Publication Publication Date Title
HRP20181364T8 (hr) Aminotriazolopiridin, namijenjen upotrebi u liječenju upale, te njegovi farmacetski pripravci
EP2818483A4 (en) MEDICINAL COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF CANCER
RS56285B1 (sr) C1-inh kompozicije za upotrebu u prevenciji i lečenju naslednog angioedema (hae)
HK1207860A1 (zh) 用於治療糖尿病及其相關病症的 -苯基- -雜環基-四氫- -吡喃- -胺化合物
EP2867239A4 (en) OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES FOR THE TREATMENT OF DIABETES
LT2854910T (lt) Ceramido lygiai infekcijos gydymo ir prevencijos metu
IL236823A0 (en) Preparations for use in the treatment of bone defects
IL233875A (en) Preparation and use for the treatment of anal fissures
ZA201408055B (en) Compositions and methods for the treatment of local pain
IL235272B (en) Alfentanil composition for the treatment of acute pain
HUE040096T2 (hu) siRNS és felhasználása eljárásokban és kompozíciókban szembajok kezelésére és/vagy megelõzésére
LT2872176T (lt) Karboranilporfirinai, skirti naudoti vėžio gydymui
HK1207289A1 (zh) 用於在失血和貧血的治療中預防血管活性的組合物
ZA201408065B (en) Compositions and methods for the treatment of diabetes
PT2676657T (pt) Composição para o tratamento de hipocalcémia em ruminantes
HK1206598A1 (zh) 用於預防和/或治療毛髮失調的伊羅替羅及其組合物
LT2863932T (lt) Kompozicija, skirta naudoti limfedemos gydymui
PL3041459T3 (pl) Kompozycje przydatne w zapobieganiu lub leczeniu raka skóry